PROLACTIN BINDING IN R3327 RAT PROSTATIC CARCINOMA CELLS

被引：0

作者：

WITORSCH, RJ ^{[1
]}

机构：

[1] VIRGINIA COMMONWEALTH UNIV,DEPT PHYSIOL,RICHMOND,VA 23298

来源：

FEDERATION PROCEEDINGS | 1978年 / 37卷 / 03期

关键词：

D O I：

暂无

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：897 / 897

页数：1

共 50 条

[1] IMMUNOHISTOCHEMICAL LOCALIZATION OF PROLACTIN-BINDING SITES IN R3327 RAT PROSTATIC-CANCER CELLS
WITORSCH, RJ
[J]. HORMONE RESEARCH, 1979, 10 (05) : 268 - 281
[2] PROLACTIN BINDING IN A HORMONE-DEPENDENT AND IN AN ANAPLASTIC SUBLINE OF THE DUNNING R3327 RAT PROSTATIC ADENOCARCINOMA
THOMPSON, SA
ALREMAIH, M
LUBAROFF, DM
JOHNSON, MP
[J]. ANATOMICAL RECORD, 1982, 202 (03): : A190 - A190
[3] FLOW KARYOLOGY OF R3327 RAT PROSTATIC ADENOCARCINOMA CELLS
THOMPSON, SA
YEN, A
LUBAROFF, DM
[J]. ANATOMICAL RECORD, 1986, 214 (03): : A134 - A135
[4] CHARACTERIZATION OF ESTROGEN-INDUCED PROGESTIN BINDING IN CYTOSOL OF THE R3327 PROSTATIC-CARCINOMA OF THE RAT
MOBBS, BG
JOHNSON, IE
[J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1985, 22 (01): : 57 - 62
[5] DIFFERENTIAL-EFFECTS OF PROLACTIN ON RAT DORSOLATERAL PROSTATE AND R3327 PROSTATIC TUMOR SUBLINES
JOHNSON, MP
THOMPSON, SA
LUBAROFF, DM
[J]. JOURNAL OF UROLOGY, 1985, 133 (06): : 1112 - 1120
[6] EFFECTS OF INTERMITTENT DIETHYLSTILBESTROL DIPHOSPHATE ADMINISTRATION ON THE R3327 RAT PROSTATIC-CARCINOMA
RUSSO, P
LIGUORI, G
HESTON, WDW
HURYK, R
YANG, CR
FAIR, WR
WHITMORE, WF
HERR, HW
[J]. CANCER RESEARCH, 1987, 47 (22) : 5967 - 5970
[7] MELATONIN AND THE GROWTH OF DUNNING R3327 RAT PROSTATIC ADENOCARCINOMAS
BUZZELL, GR
AMERONGEN, HM
TOMA, JG
[J]. NEUROENDOCRINOLOGY LETTERS, 1987, 9 (05) : 297 - 297
[8] DEVELOPMENT OF AN INVITRO CLONOGENIC-ASSAY FOR THE R3327 RAT PROSTATIC ADENOCARCINOMA PERMITS COMPARISON OF THE PROLIFERATIVE POTENTIAL OF THE R3327, R3327A, AND R3327AT TUMORS
DIBNER, JJ
NAKEFF, A
[J]. PROSTATE, 1983, 4 (03): : 289 - 306
[9] PROSTATIC TUMOR (R3327) SKELETAL METASTASIS
GELDOF, AA
RAO, BR
[J]. PROSTATE, 1990, 16 (04): : 279 - 290
[10] Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma
Zaccheo, T
Giudici, D
diSalle, E
[J]. PROSTATE, 1997, 30 (02): : 85 - 91

← 1 2 3 4 5 →